Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea
· Delayed Price · Currency is KRW 86,600
-1,600 (-1.81%)
Last updated: Apr 29, 2026, 2:20 PM KST
KRX:185750 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,162,129 | 1,092,296 | 1,178,982 | 1,665,713 | 1,001,820 | 1,312,265 | Upgrade
|
| Market Cap Growth | 15.60% | -7.35% | -29.22% | 66.27% | -23.66% | -49.00% | Upgrade
|
| Enterprise Value | 1,185,986 | 1,169,904 | 1,062,300 | 1,643,506 | 1,090,150 | 1,317,515 | Upgrade
|
| Last Close Price | 88200.00 | 82900.00 | 88479.53 | 122485.74 | 72561.99 | 92402.74 | Upgrade
|
| PE Ratio | 15.09 | 14.09 | 10.81 | 7.84 | 12.38 | 30.72 | Upgrade
|
| Forward PE | 16.24 | 14.47 | 14.47 | 18.84 | 11.98 | 14.96 | Upgrade
|
| PS Ratio | 0.69 | 0.65 | 0.74 | 1.00 | 0.67 | 0.98 | Upgrade
|
| PB Ratio | 1.15 | 1.09 | 1.32 | 2.04 | 1.61 | 2.32 | Upgrade
|
| P/TBV Ratio | 1.27 | 1.20 | 1.44 | 2.18 | 1.68 | 2.41 | Upgrade
|
| P/FCF Ratio | - | - | 45.67 | 6.02 | 43.87 | - | Upgrade
|
| P/OCF Ratio | 17.25 | 16.22 | 18.34 | 5.24 | 14.79 | 101.70 | Upgrade
|
| PEG Ratio | - | 8.17 | 8.17 | 8.17 | 8.17 | 8.17 | Upgrade
|
| EV/Sales Ratio | 0.70 | 0.69 | 0.67 | 0.98 | 0.73 | 0.98 | Upgrade
|
| EV/EBITDA Ratio | 9.46 | 9.33 | 7.63 | 5.80 | 7.60 | 10.78 | Upgrade
|
| EV/EBIT Ratio | 14.72 | 14.52 | 10.68 | 6.67 | 9.92 | 13.90 | Upgrade
|
| EV/FCF Ratio | -16.12 | - | 41.15 | 5.93 | 47.74 | - | Upgrade
|
| Debt / Equity Ratio | 0.37 | 0.37 | 0.21 | 0.27 | 0.38 | 0.42 | Upgrade
|
| Debt / EBITDA Ratio | 2.93 | 2.93 | 1.35 | 0.77 | 1.64 | 1.94 | Upgrade
|
| Debt / FCF Ratio | - | - | 7.29 | 0.79 | 10.32 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.02 | 0.02 | -0.13 | -0.18 | 0.13 | 0.09 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.17 | 0.17 | -0.82 | -0.51 | 0.56 | 0.41 | Upgrade
|
| Net Debt / FCF Ratio | -0.29 | -0.29 | -4.42 | -0.52 | 3.50 | -1.41 | Upgrade
|
| Asset Turnover | 1.04 | 1.04 | 1.11 | 1.32 | 1.37 | 1.35 | Upgrade
|
| Inventory Turnover | 2.98 | 2.98 | 3.43 | 3.79 | 3.82 | 4.13 | Upgrade
|
| Quick Ratio | 1.25 | 1.25 | 1.63 | 1.32 | 1.16 | 1.30 | Upgrade
|
| Current Ratio | 2.12 | 2.12 | 2.61 | 1.85 | 1.91 | 2.08 | Upgrade
|
| Return on Equity (ROE) | 8.18% | 8.18% | 13.02% | 29.73% | 13.47% | 7.58% | Upgrade
|
| Return on Assets (ROA) | 3.09% | 3.09% | 4.35% | 12.20% | 6.33% | 5.94% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.50% | 8.49% | 13.69% | 31.79% | 13.74% | 8.73% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.30% | 6.30% | 9.10% | 27.70% | 14.60% | 13.00% | Upgrade
|
| Earnings Yield | 6.67% | 7.10% | 9.25% | 12.76% | 8.08% | 3.26% | Upgrade
|
| FCF Yield | -6.33% | -6.73% | 2.19% | 16.63% | 2.28% | -2.69% | Upgrade
|
| Payout Ratio | 17.84% | 17.84% | 12.22% | 5.46% | 13.88% | 25.30% | Upgrade
|
| Buyback Yield / Dilution | -0.50% | -0.50% | 5.20% | -3.79% | 1.77% | 0.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.